CinCor Pharma Inc

NASDAQ:CINC   3:59:54 PM EDT
14.62
+0.47 (+3.32%)
Earnings Announcements

Cincor Reports Q4 And Full-Year 2021 Financial Results

Published: 03/22/2022 13:27 GMT
CinCor Pharma Inc (CINC) - Cincor Reports Fourth Quarter and Full-year 2021 Financial Results and Provides Corporate Update.
Cincor Pharma Inc - Qtrly Net and Comprehensive Loss per Share $15.71.
Cincor Pharma Inc - Cash and Cash Equivalents Were $136.6 Million As of December 31, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.50

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.58

More details on our Analysts Page.